Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I5VG
|
|||
| Drug Name |
PMID25656651-Compound-29b
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
HANMI SCIENCE CO., LTD. KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION SON, Jung Beom JUNG, Seung Hyun CHOI, Wha Il JUNG, Young Hee CHOI, Jae Yul SONG, Ji Yeon LEE, Kyu Hang LEE, Jae Chul KIM, Eun Young AHN, Young Gil KIM, Maeng Sup CHOI, Hwan Geun SIM, Tae Bo HAM, Young Jin PARK, Dong-sik KIM, Hwan KIM, Dong-Wook
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H22FN7O2S
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)NC(=O)C2=CC(=NN2CC3=CC=C(C=C3)F)C)NC(=O)C4=CSC5=C4N=CN=C5N
|
|||
| InChI |
1S/C26H22FN7O2S/c1-14-3-8-18(10-20(14)32-25(35)19-12-37-23-22(19)29-13-30-24(23)28)31-26(36)21-9-15(2)33-34(21)11-16-4-6-17(27)7-5-16/h3-10,12-13H,11H2,1-2H3,(H,31,36)(H,32,35)(H2,28,29,30)
|
|||
| InChIKey |
XYZZDCAVPVYIRF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.